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Introduction 
Magnetic resonance imaging (MRI) can provide a wealth of information about inflammation, erosions, fusion 
and fat metaplasia in the sacroiliac joints in patients with enthesitis-related arthritis (ERA). However, there is 
currently a lack of information regarding the natural history of imaging findings when patients are treated 
with biologic therapy. The aim of this study was to evaluate the disease course of patients with enthesitis-
related arthritis after biologic treatment using repeat MRI scans before and after treatment.  
 
Materials and Methods 
A picture archiving and communication system (PACS) search was used to identify all adolescent patients 
aged 12-24 with ERA who had undergone at least three MRI scans of the sacroiliac joints, over at least a two-
year period, with scans before and after biologic treatment. Each scan was scored for inflammation according 
to the Spondyloarthritis Research Consortium of Canada scoring system1, and for erosions, fat metaplasia and 
fusion using a recently proposed structural score2.  
 
Results 
Twenty-two patients were identified for the study. Patients were started on biologics at a mean age of 17y2m, 
and the mean number of scans per patient was 3.9. Scans were acquired between 3.5 years before starting 
biologics and 7.8 years after starting biologics. Graphs showing inflammation, erosions, fat metaplasia and 
fusion over time from biologic start are shown in Figure 1.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Scores for inflammation and erosions were both significantly lower after treatment than before treatment 
(p<0.001). Fusion and fat metaplasia scores were significantly higher after treatment (p<0.001).   
 
Discussion 
These data suggest that ERA patients undergo a reduction in inflammation but a substantial increase in fusion 
and fat metaplasia after biologic treatment. These findings are consistent with studies in adult 
spondyloarthritis which suggest a link between resolution of inflammation and new bone formation during 
biologic therapy3.  
 
Conclusions 
Biologic treatment in enthesitis-related arthritis effectively reduces inflammation, but fails to prevent fusion. 
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Figure 1 - – scatterplots showing inflammation, erosions, fat metaplasia and fusion over time from biologic start. 
Biologic therapy was started at time 0. Repeated data from individual patients are joined by dotted lines. 
